In the Review by Harris et al. published in the February 2009 issue of Nature Clinical Practice Urology, the competing interests information was incorrect. The correct competing interests information should read 'PS Nelson has declared associations with the following company/organization: GlaxoSmithKline. B Montgomery has declared associations with the following companies/organizations: Cougar Biotechnology and GlaxoSmithKline. See the article online for full details of the relationships. The other authors declared no competing interests.' PS Nelson has acted as a consultant and received grant/research support from GlaxoSmithKline. B Montgomery has received grant/research support from GlaxoSmithKline as well as Cougar Biotechnology.
Additional information
The online version of the original article can be found at 10.1038/ncpuro1296
Rights and permissions
About this article
Cite this article
Harris, W., Mostaghel, E., Nelson, P. et al. Erratum: Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Rev Urol 6, 173 (2009). https://doi.org/10.1038/ncpuro1322
Issue Date:
DOI: https://doi.org/10.1038/ncpuro1322
